Clinical Trial Update: Dexamethasone to Treat Acute Chest Syndrome in People With Sickle Cell Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dexamethasone for acute chest syndrome in people with sickle cell disease was terminated, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chest Syndrome
• Sickle Cell Disease

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Anemia, Sickle Cell | Phase 3 | Status: TERMINATED | Results posted: 2009-12-31